GSK Investors Alert: Class Action Lawsuit for Securities Fraud and Health Risks Pomerantz LLP has initiated a class action lawsuit against GSK plc. Investors who suffered losses are encouraged to join before the April deadline.

GSK Investors Alert: Class Action Lawsuit for Securities Fraud and Health Risks #United_States #New_York #Pomerantz_Law #GSK_Plc #Zantac_Recall

Understanding the Implications of the GSK Securities Class Action for Investors A recent class action against GSK plc highlights critical investor concerns regarding its Zantac recall. Learn about the implications and deadlines.

Understanding the Implications of the GSK Securities Class Action for Investors #Robbins_LLP #London #United_Kingdom #GSK_Plc #Zantac_Recall